Pharmaceuticals CEO Plans to Cut Prices Following the Backlash After AIDS Drug Price Hike

Pharmaceuticals CEO Plans to Cut Prices Following the Backlash After AIDS Drug Price Hike

Almost as quickly as he became the most hated man in America, Martin Shkreli has decided to reduce the price of Daraprim. The 32-year-old Turing Pharmaceuticals CEO recently bought the rights to sell the drug in America and immediately hiked the price up from $13.50 to $750 a pill.

After mass criticism to what has been perceived as a greedy move to exploit those with AIDS, Shkreli told NBC News about his decision to cut the price:

“Yes it is absolutely a reaction — there were mistakes made with respect to helping people understand why we took this action, I think that it makes sense to lower the price in response to the anger that was felt by people… I think in the society we live in today, it’s easy to want to villainize people, and obviously we’re in an election cycle where this is very, very tough topic for people and it’s very sensitive. And I understand the outrage.”

The price gouge was followed by response from the Democratic presidential hopefuls. Hillary Clinton outlined a plan to cap prescription drug costs at $250 a month while Bernie Sanders pushed his own plan and reiterated his track record of advocating for lower drug costs.

Clinton tweeted about her plan, causing the Biotech index to go into a frenzy:tweet

Shkreli argued that the production cost of the drug is low, but that does not factor in quality control and regulatory costs:

“It’s very easy to see a large drug price increase and say ‘Gosh, those people must be gouging.’ But when you find out that the company is not really making any money, what does that mean?”

Although it’s not clear what the deflated price will be, Shkreli still hopes to break even or make a small profit. The new price will be determined within the next few weeks.

Long-term AIDS activist, Peter Staley chimed in on Shkreli’s actions with a statement for Out:

“In the end, Shkreli did us all a big favor by launching a long-overdue national discussion around our nation’s very broken drug pricing system. AIDS activists have been protesting this for decades. We shut down trading on the New York Stock Exchange in 1989 over AZT’s price, which was lowered three days later. Now Shkreli has backed down. But we can’t keep fighting these drug-by-drug battles. We desperately need some common sense government regulation, like every other country on the planet.”

Previous THE QUESTION: ARE YOU PREPARED FOR WHAT LIES AHEAD?
Next The Cinderella Complex

About author

You might also like

The Happenings 3 Comments

TIERs presents the poster of upcoming movie

All week, The Initiative for Equal Rights (TIERs) had been teasing us with behind-the-scenes photos of an upcoming movie project simply identified with the hashtag #WDLHA. Today, they finally unveiled

The Happenings 8 Comments

A ‘Mostly Top’ Guy learns a tough lesson about cancelling on your Bottom

A guy who identifies as “mostly top” found the shoe on the other foot after he spent hours preparing for bottoming, only to receive nothing but excuses. Andy, a marketing

The Happenings 11 Comments

Eddie Redmayne dazzles in ‘The Danish Girl’ movie posters

The first posters for transgender period drama, The Danish Girl, have been released. The Brit actor has taken on the role of transgender pioneer Lili Elbe for the film directed

5 Comments

  1. Francis
    September 24, 05:43 Reply

    Na because of people like Martin, HIV infected populations are pessimistic about a cure. According to them, the money HIV generates is too immense for someone to standby and watch a cure end it all. Talk about killing the golden goose with a cure.

    • Pink Panther
      September 24, 11:29 Reply

      Corporations like this with a very high-demand market are usually like that. Ruthless.

      • Francis
        September 24, 12:00 Reply

        Make we dey thank God for the life of selfless peeps like Bill Gates. Africanos for don die plenty.

Leave a Reply